CoChat

Lymphocytic Vasculitis of the Uterus in a Patient With Melanoma Receiving Ipilimumab

Minor, David R., Bunker, Stephen R., Doyle, Judith · 2013 · Journal of Clinical Oncology
Cited by 37

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Case Report A 77-year-old woman developed in-transit and lymphatic metastases from melanoma after multiple previous therapies. She received four dosesof ipilimumab3mg/kgbeginninginSeptember2011.Fifteenweeks after starting treatment, she developed hypophysitis with low levels of cortisol and thyroid-stimulating hormone; her symptoms responded to appropriate hormonal replacement. Positron emission tomography (PET)/computed tomography scan in May 2012 documented complete remission of her melanoma. She received additional doses of ipilimumab 3 mg/kg in March and June 2012 without apparent adverse effects. A routine PET/computed tomography scan in August 2012 appeared to show a 4.8-cm mass in the uterus (SUV 9.2) with bilateral iliac lymphadenopathy (Fig 1). She had no pelvic pain, bleeding, or previous gynecological disease. Because of suspicion of recurrent malignancy she had a hysterectomy in September 2012. Pathology showed lymphocytic vasculitis involving uterine and ovarian vessels (Fig 2), with transmural infiltration of lymphocytes and focal fibrin deposition. The iliac lymph nodes thatwereremovedshowedonlyreactivechanges.Serologic studies subsequently showed normal antinuclear antibodies but a high titer of antithyroglobulin antibody—3,591 IU/mL (normal, 0-40 IU/mL).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2012.47.5095

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 37

Metadata

Authors
Minor, D. R., Bunker, S. R., & Doyle, J.
Venue
Journal of Clinical Oncology
Published
2013-07-10
Volume
31
Issue
20
Pages
e356-e356
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2171580322
Cited by
37
References
1
FWCI
1.26
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.